Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)

Thomas M. MacDonald, Isla S. Mackenzie, Li Wei, Christopher J. Hawkey, Ian Ford

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)'. Together they form a unique fingerprint.

    Medicine & Life Sciences